A deep dive into the Fc–FcR axis as a therapeutic anchor in autoimmune disease, examining immune signaling and drug ...

According to DelveInsight’s latest analysis, Nipocalimab is expected to capture meaningful market share across both prevalent ...

Full-year 2025 preliminary1 U.S. net product revenues of $689 millionSYFOVRE® (pegcetacoplan injection) total injection demand grew 17% ...

SPRING HOUSE, PA — Johnson & Johnson (NYSE: JNJ) said its experimental immune therapy nipocalimab cleared a major clinical ...

Explore how peptide drugs are changing the hundred-billion-level weight loss market, and how this landscape is changing as new antibody drugs emerge.

CD BioGlyco leverages its state-of-the-art platform and years of experience to deliver precise and consistent modifications to your antibody glycans. Researchers can now access homogeneous glycoforms ...

One of the most exciting advances in cancer treatments in the past decade is the development of T cell immunotherapies, in which a patient's own immune system is trained to recognize and attack ...

Checkpoint inhibitors have revolutionized cancer treatment by enhancing T-cell responses against tumors, leading to long-term tumor regression. These inhibitors, including anti-PD-1/PD-L1 and ...

Now researchers from Japan's Okayama University of Science have found another way bitter taste receptors function in cancer cells. They discovered that the receptors, known as TAS2Rs, become activated ...

SAN FRANCISCO — Efgartigimod (Vyvgart), a neonatal Fc receptor (FcRn) antagonist, significantly improved symptoms in patients with anti-acetylcholine receptor antibody (AChR-Ab)-negative generalized ...

aCancer Centre, The First Hospital of Jilin University, Changchun, Jilin, 130021, China bInstitute of Virology and AIDS Research, The First Hospital of Jilin University, Changchun, Jilin, 130021, ...

Three distinct snapshots obtained with cryo-electron microscopy illustrate the arrangement of two of the four symmetrical subunits that make a functional NMDA receptor. During activation, as the ...